JP2005527493A - 光線力学療法のためのシステムおよび方法 - Google Patents

光線力学療法のためのシステムおよび方法 Download PDF

Info

Publication number
JP2005527493A
JP2005527493A JP2003561639A JP2003561639A JP2005527493A JP 2005527493 A JP2005527493 A JP 2005527493A JP 2003561639 A JP2003561639 A JP 2003561639A JP 2003561639 A JP2003561639 A JP 2003561639A JP 2005527493 A JP2005527493 A JP 2005527493A
Authority
JP
Japan
Prior art keywords
patient
photoreactive agent
retina
eye
photoreactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003561639A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005527493A5 (https=
Inventor
ジェイムズ・チェン
ジュリーン・クリストファーセン
ニック・イェオ
グレッグ・ヒーコック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Light Sciences Corp
Original Assignee
Light Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Light Sciences Corp filed Critical Light Sciences Corp
Publication of JP2005527493A publication Critical patent/JP2005527493A/ja
Publication of JP2005527493A5 publication Critical patent/JP2005527493A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/0079—Methods or devices for eye surgery using non-laser electromagnetic radiation, e.g. non-coherent light or microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00863—Retina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F9/009—Auxiliary devices making contact with the eyeball and coupling in laser light, e.g. goniolenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes
    • A61N2005/0652—Arrays of diodes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Optics & Photonics (AREA)
  • Electromagnetism (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2003561639A 2002-01-23 2003-01-23 光線力学療法のためのシステムおよび方法 Pending JP2005527493A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35146002P 2002-01-23 2002-01-23
PCT/US2003/002303 WO2003061696A2 (en) 2002-01-23 2003-01-23 Systems and methods for photodynamic therapy

Publications (2)

Publication Number Publication Date
JP2005527493A true JP2005527493A (ja) 2005-09-15
JP2005527493A5 JP2005527493A5 (https=) 2006-03-09

Family

ID=27613501

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003561639A Pending JP2005527493A (ja) 2002-01-23 2003-01-23 光線力学療法のためのシステムおよび方法

Country Status (5)

Country Link
US (1) US20030167033A1 (https=)
EP (1) EP1467760A2 (https=)
JP (1) JP2005527493A (https=)
CA (1) CA2473924A1 (https=)
WO (1) WO2003061696A2 (https=)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007086395A1 (ja) * 2006-01-24 2007-08-02 Hamamatsu Foundation For Science And Technology Promotion 光線力学的療法用キット
JP2010513363A (ja) * 2006-12-22 2010-04-30 バイオフロンテラ バイオサイエンス ゲゼルシャフト ミット ベシュレンクテル ハフツング ナノエマルジョン
JP2012508189A (ja) * 2008-11-07 2012-04-05 クロクス テクノロジーズ インコーポレイテッド 創傷治癒のための酸化剤および光活性化剤の組み合わせ
JP2012533522A (ja) * 2009-07-17 2012-12-27 クロクス テクノロジーズ インコーポレイテッド 口腔内消毒および口腔疾患の処置のための酸化剤、光増感剤および創傷治癒剤の組み合わせ
KR20140048878A (ko) * 2011-04-29 2014-04-24 오삐또 유니베르시테르 드 제네브 각막 질환의 치료 및/또는 예방을 위한 장치
JP2014185151A (ja) * 2013-03-22 2014-10-02 Wuxi Zhaozhen Radiation Technology Co Ltd 速立酸素による病気を治療するウィルス不活薬物を調製する応用
JP2016531591A (ja) * 2013-09-18 2016-10-13 オーラ バイオサイエンシーズ， インコーポレイテッド 腫瘍を診断および処置するためのウイルス様粒子結合体
JP2017517534A (ja) * 2014-06-09 2017-06-29 クロクス テクノロジーズ インコーポレイテッド シリコンベースの生体光組成物およびその使用
US10300150B2 (en) 2012-02-07 2019-05-28 Aura Biosciences, Inc. Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
US10688172B2 (en) 2009-04-13 2020-06-23 INSERM (Institut National de la Santé et de la Recherche Médicale) HPV particles and uses thereof
US12589165B2 (en) 2017-04-12 2026-03-31 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
JP2002534483A (ja) * 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 代謝性骨障害または骨転移のための治療的組成物
US6454789B1 (en) 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
JP2002534218A (ja) 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 非侵襲性の脈管療法
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
EP1267935A2 (en) * 2000-01-12 2003-01-02 Light Sciences Corporation Novel treatment for eye disease
US7041121B1 (en) * 2002-01-31 2006-05-09 Medtronicvidamed, Inc. Apparatus for treating prostate cancer and method for same
EP1517684B1 (en) 2002-06-27 2009-07-22 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
WO2004005289A2 (en) 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
US7699058B1 (en) 2002-11-08 2010-04-20 Jay Harvey H Hair treatment method
US7931028B2 (en) * 2003-08-26 2011-04-26 Jay Harvey H Skin injury or damage prevention method using optical radiation
CN2885311Y (zh) 2006-01-18 2007-04-04 郑成福 经尿道光动力疗法前列腺治疗仪
US10376711B2 (en) 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
CA2465051C (en) * 2003-04-23 2014-11-18 John Tulip Switched photodynamic apparatus
US7090670B2 (en) * 2003-12-31 2006-08-15 Reliant Technologies, Inc. Multi-spot laser surgical apparatus and method
US7706863B2 (en) 2004-01-21 2010-04-27 University Of Washington Methods for assessing a physiological state of a mammalian retina
JP2007521890A (ja) * 2004-02-13 2007-08-09 キュー エル ティー インク． 前立腺状態の治療のための光線力学療法
US7992570B2 (en) * 2004-04-22 2011-08-09 Light Sciences Oncology, Inc. Fractionated light PDT therapy for posterior eye disease
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
WO2006036176A1 (en) * 2004-09-24 2006-04-06 Light Sciences Corporation Extended treatment of tumors through vessel occlusion with light activated drugs
WO2006041744A2 (en) * 2004-10-05 2006-04-20 Light Sciences Corporation Low energy pdt for ocular disease
JPWO2006049132A1 (ja) * 2004-11-02 2008-05-29 学校法人慶應義塾 光線力学的治療装置
US20060122619A1 (en) * 2004-12-03 2006-06-08 Kablik Joseph J Devices and systems for illuminating or irradiating a light-sensitive sealant for polymerization and cross-linking and methods of using the same
US20080139804A1 (en) * 2005-01-14 2008-06-12 Naohiro Kanayama Photosensitive Compounds
US20060229689A1 (en) * 2005-04-08 2006-10-12 Led Technologies, Llc LED therapy device
JP2009506835A (ja) * 2005-08-29 2009-02-19 リライアント・テクノロジーズ・インコーポレイテッド 熱誘起組織治療を監視し制御する方法および装置
US20070049996A1 (en) * 2005-08-29 2007-03-01 Reliant Technologies, Inc. Monitoring Method and Apparatus for Fractional Photo-Therapy Treatment
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007033180A1 (en) * 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
EP1937286B1 (en) 2005-09-12 2016-03-09 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
EP1966229B1 (en) 2005-09-12 2015-10-21 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
BR122015013776B1 (pt) 2005-11-09 2016-12-06 Klox Technologies Inc composição, método para branqueamento de dentes e kit
US20080177220A1 (en) * 2006-01-06 2008-07-24 The Curators Of The University Of Missouri Ultrasound-Mediated Transcleral Drug Delivery
US7950396B2 (en) * 2006-04-28 2011-05-31 Ondine International Holdings Ltd. Treatment for otitis externa
US20090204185A1 (en) * 2006-06-14 2009-08-13 Koninklijke Philips Electronics N.V. Photothereapy device
CN101500640B (zh) * 2006-06-15 2013-10-16 海鸥Ip有限公司 递送系统和方法
DE102006030219A1 (de) * 2006-06-30 2008-01-03 Iroc Ag Bestrahlungssystem für medizinische Anwendungen
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
US8435234B2 (en) * 2007-02-06 2013-05-07 Reliant Technologies, Inc. Method and apparatus for monitoring and controlling laser-induced tissue treatment
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
MX2009010000A (es) 2007-03-19 2010-03-17 Insuline Medical Ltd Dispositivo para el suministro de farmaco.
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US20090117053A1 (en) * 2007-11-06 2009-05-07 Boston Scientific Scimed, Inc. Local delivery of 5-aminolevulinic-acid based compounds to tissues and organs for diagnostic and therapeutic purposes
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
WO2009102756A1 (en) * 2008-02-13 2009-08-20 Andreas Rose Light delivery device that provides a radial light output pattern
US9358369B1 (en) * 2008-08-13 2016-06-07 Abbott Cardiovascular Systems Inc. Reduced profile and enhanced flexibility delivery catheters for light activated agents
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
CA2743027C (en) 2008-11-07 2016-04-12 Insuline Medical Ltd. Device and method for drug delivery
US8771741B2 (en) * 2009-01-23 2014-07-08 The Penn State Research Foundation In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles
WO2011053874A1 (en) 2009-10-30 2011-05-05 Tandem Abela Development Group Llc Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
US20110206737A1 (en) * 2010-02-24 2011-08-25 Empire Technology Development Llc Photosensitizer-containing composition
JP5719159B2 (ja) * 2010-03-15 2015-05-13 ソニー株式会社 評価装置
JP6377906B2 (ja) 2010-03-19 2018-08-22 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 眼治療を適用およびモニターするためのシステム
WO2012167260A2 (en) 2011-06-02 2012-12-06 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
CN103608662B (zh) * 2011-06-29 2016-09-28 京都府公立大学法人 肿瘤部位的识别装置以及识别方法
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US20140105832A1 (en) 2012-09-14 2014-04-17 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
US10881736B2 (en) 2013-07-03 2021-01-05 Klox Technologies Inc. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
US20160367672A1 (en) * 2014-03-03 2016-12-22 University Of Southern California Methods and systems for treating tumors
CA2944201A1 (en) 2014-04-01 2015-10-08 Klox Technologies Inc. Tissue filler compositions and methods of use
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
KR102545628B1 (ko) 2014-10-27 2023-06-20 아베드로 인코퍼레이티드 눈의 교차-결합 처리를 위한 시스템 및 방법
KR20170077153A (ko) 2014-10-31 2017-07-05 클록스 테크놀로지스 인크. 광활성 섬유 및 직물 매질
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
JP6289666B2 (ja) * 2014-11-19 2018-03-07 シャープ株式会社 光線力学治療装置
EP3285704B1 (en) 2015-04-24 2020-11-18 Avedro Inc. Systems for photoactivating a photosensitizer applied to an eye
US10028657B2 (en) 2015-05-22 2018-07-24 Avedro, Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
KR102706856B1 (ko) 2015-07-21 2024-09-19 아베드로 인코퍼레이티드 광증감제로 눈을 치료하기 위한 시스템 및 방법
CN106620893B (zh) 2015-07-23 2021-07-30 爱博诺德(北京)医疗科技股份有限公司 用于眼部疾病光治疗的材料
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing
ES2972417T3 (es) * 2016-05-18 2024-06-12 Sonikure Holdings Ltd Sistema de administración transescleral de fármacos mejorada por ultrasonidos
US11850188B2 (en) 2019-04-01 2023-12-26 Amo Development, Llc Corneal lenticule extraction tool
WO2021202398A1 (en) * 2020-03-30 2021-10-07 University Of Miami Photodynamic antimicrobial therapy device
US11612669B2 (en) 2020-08-21 2023-03-28 University Of Washington Disinfection method and apparatus
US11529153B2 (en) 2020-08-21 2022-12-20 University Of Washington Vaccine generation
US11425905B2 (en) 2020-09-02 2022-08-30 University Of Washington Antimicrobial preventive netting
US11458220B2 (en) 2020-11-12 2022-10-04 Singletto Inc. Microbial disinfection for personal protection equipment
CN112451862B (zh) * 2020-11-24 2023-03-28 深圳罗兹曼国际转化医学研究院 光动力治疗系统及其控制方法
US12359369B2 (en) 2022-08-11 2025-07-15 Singletto Inc. Skin protection against microbial particles
WO2024208434A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Pressurized nanoemulsion
WO2024208433A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoemulsion without propylene glycol

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US178458A (en) * 1876-06-06 Improvement in pessaries
US41725A (en) * 1864-02-23 Improvement in button-hole cutters
US41727A (en) * 1864-02-23 Improvement in fibrous batting or wadding
US41768A (en) * 1864-03-01 Improvement in wrenches
US10500A (en) * 1854-02-07 Tool-holder
US127224A (en) * 1872-05-28 Improvement in cotton-seed cleaners
US87205A (en) * 1869-02-23 Improved velocipede
US127230A (en) * 1872-05-28 Improvement in lamp-chimney cleaners
US178216A (en) * 1876-05-30 Improvement in electro-magnetic annunciators
US114434A (en) * 1871-05-02 Improvement in dry-earth closets
US41726A (en) * 1864-02-23 Improved mode of raising sunken vessels
US151087A (en) * 1874-05-19 Improvement in stench-traps
US46983A (en) * 1865-03-28 Improvement in treating ores
US115694A (en) * 1871-06-06 William e
US217690A (en) * 1879-07-22 Improvement in mechanical telephones
US4521762A (en) * 1981-08-27 1985-06-04 Gte Automatic Electric Laboratories, Incorporated Integratable D/A converter
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4577636A (en) * 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US5216012A (en) * 1986-01-02 1993-06-01 University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5494793A (en) * 1986-12-15 1996-02-27 British Technology Group Usa Inc. Monomeric phthalocyanine reagents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5004811A (en) * 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
US4823244A (en) * 1988-01-29 1989-04-18 Niagara Medical Innovations Inc. Light source assembly
US5026367A (en) * 1988-03-18 1991-06-25 Cardiovascular Laser Systems, Inc. Laser angioplasty catheter and a method for use thereof
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US4998930A (en) * 1988-08-03 1991-03-12 Phototherapeutic Systems Intracavity laser phototherapy method
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US4997639A (en) * 1989-11-27 1991-03-05 Nippon Petrochemicals Company, Limited Method for detecting cholesterol deposited in bodies of mammals
US5594136A (en) * 1989-12-21 1997-01-14 Pharmacyclics, Inc. Texaphyrin solid supports and devices
EP0510007B1 (en) * 1990-01-08 1996-05-08 Health Research, Inc. A submersible lens fiberoptic assembly
US5484778C1 (en) * 1990-07-17 2001-05-08 Univ Cleveland Hospitals Phthalocynine photosensitizers for photodynamic therapy and methods for their use
US5500009A (en) * 1990-11-15 1996-03-19 Amron, Ltd. Method of treating herpes
JP3154742B2 (ja) * 1991-04-30 2001-04-09 日本石油化学株式会社 哺乳類の動脈硬化症治療剤
US5769844A (en) * 1991-06-26 1998-06-23 Ghaffari; Shahriar Conventional light-pumped high power system for medical applications
US5330741A (en) * 1992-02-24 1994-07-19 The Regents Of The University Of California Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors
EP1306095A3 (en) * 1992-03-05 2003-06-25 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
EP1138334A3 (en) * 1992-06-09 2002-04-03 Neorx Corporation Pretargeting methods and compounds
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US5298018A (en) * 1992-08-14 1994-03-29 Pdt Cardiovascular, Inc. Method for treating cardiovascular disease through adjunctive photodynamic therapy
FI951295A7 (fi) * 1992-09-21 1995-05-17 Quadra Logic Tech Inc Ihon läpi tapahtuva veressä olevien valoherkkien aineiden in vivo-akti vointi
ATE189966T1 (de) * 1992-11-20 2000-03-15 Univ British Columbia Aktivierung von photoempfindlichen mitteln
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
US5420768A (en) * 1993-09-13 1995-05-30 Kennedy; John Portable led photocuring device
US5514669A (en) * 1993-09-29 1996-05-07 Medical College Of Ohio Use of photodynamic therapy to treat prostatic tissue
US5913834A (en) * 1993-11-04 1999-06-22 Francais; Caramia System for imparting sensory effects across a mother's abdomen to a fetus and monitoring effects on the fetus
US6015897A (en) * 1993-12-07 2000-01-18 Neorx Corporation Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota
IL108918A (en) * 1994-03-10 1997-04-15 Medic Lightech Ltd Apparatus for efficient photodynamic treatment
US5616140A (en) * 1994-03-21 1997-04-01 Prescott; Marvin Method and apparatus for therapeutic laser treatment
US5498710A (en) * 1994-04-22 1996-03-12 Health Research, Inc. Alkyl ether analogues of benzoporphyrin derivatives
US5591847A (en) * 1994-05-23 1997-01-07 Health Research, Inc. Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages
US5519534A (en) * 1994-05-25 1996-05-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Irradiance attachment for an optical fiber to provide a uniform level of illumination across a plane
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5746494A (en) * 1994-11-22 1998-05-05 Asahi Kogaku Kogyo Kabushiki Kaisha Illuminating apparatus of endoscope
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
US5735817A (en) * 1995-05-19 1998-04-07 Shantha; T. R. Apparatus for transsphenoidal stimulation of the pituitary gland and adjoining brain structures
US5571152A (en) * 1995-05-26 1996-11-05 Light Sciences Limited Partnership Microminiature illuminator for administering photodynamic therapy
JPH0947518A (ja) * 1995-06-26 1997-02-18 Lederle Japan Ltd フォトダイナミックセラピ用光ファイバレーザ導光プローブ
IT1275571B (it) * 1995-07-19 1997-08-07 Consiglio Nazionale Ricerche Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori
JP2961074B2 (ja) * 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
US5912257A (en) * 1995-09-06 1999-06-15 The Research Foundation Of State University Of New York Two-photon upconverting dyes and applications
US5885557A (en) * 1996-02-08 1999-03-23 Estee Lauder Inc. Compositions useful in the phototherapeutic treatment of proliferative skin disorders
US5800478A (en) * 1996-03-07 1998-09-01 Light Sciences Limited Partnership Flexible microcircuits for internal light therapy
US5770730A (en) * 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
US5756541A (en) * 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
US6013053A (en) * 1996-05-17 2000-01-11 Qlt Photo Therapeutics Inc. Balloon catheter for photodynamic therapy
US5709653A (en) * 1996-07-25 1998-01-20 Cordis Corporation Photodynamic therapy balloon catheter with microporous membrane
US5904147A (en) * 1996-08-16 1999-05-18 University Of Massachusetts Intravascular catheter and method of controlling hemorrhage during minimally invasive surgery
US5715837A (en) * 1996-08-29 1998-02-10 Light Sciences Limited Partnership Transcutaneous electromagnetic energy transfer
US5849027A (en) * 1996-09-04 1998-12-15 Mbg Technologies, Inc. Photodynamic therapy method and apparatus
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
EP0945454B1 (en) * 1996-10-01 2003-07-02 Wyeth Lederle Japan LTD. Iminochlorinaspartic acid derivatives
US5741316A (en) * 1996-12-02 1998-04-21 Light Sciences Limited Partnership Electromagnetic coil configurations for power transmission through tissue
US6080160A (en) * 1996-12-04 2000-06-27 Light Sciences Limited Partnership Use of shape memory alloy for internally fixing light emitting device at treatment site
US6021347A (en) * 1996-12-05 2000-02-01 Herbst; Ewa Electrochemical treatment of malignant tumors
US5766222A (en) * 1997-07-07 1998-06-16 Petit; Michael G. Nipple illuminator for photodynamic therapy
US6058937A (en) * 1997-07-18 2000-05-09 Miravant Systems, Inc. Photodynamic Therapy of highly vascularized tissue
US6183444B1 (en) * 1998-05-16 2001-02-06 Microheart, Inc. Drug delivery module
US5865840A (en) * 1997-10-22 1999-02-02 Light Sciences Limited Partnership Enhancement of light activation effect by immune augmentation
US6071944A (en) * 1997-11-12 2000-06-06 Bowling Green State University Method of treatment of pigmented cancer cells utilizing photodynamic therapy
US20030030342A1 (en) * 1998-02-10 2003-02-13 Chen James C. Contactless energy transfer apparatus
US6344050B1 (en) * 1998-12-21 2002-02-05 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
US6210425B1 (en) * 1999-07-08 2001-04-03 Light Sciences Corporation Combined imaging and PDT delivery system
US6238426B1 (en) * 1999-07-19 2001-05-29 Light Sciences Corporation Real-time monitoring of photodynamic therapy over an extended time
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US6534040B2 (en) * 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US6520669B1 (en) * 2000-06-19 2003-02-18 Light Sciences Corporation Flexible substrate mounted solid-state light sources for exterior vehicular lighting
US6559374B2 (en) * 2000-07-21 2003-05-06 North Carolina State University Trans beta substituted chlorins and methods of making and using the same
US6580228B1 (en) * 2000-08-22 2003-06-17 Light Sciences Corporation Flexible substrate mounted solid-state light sources for use in line current lamp sockets
EP1517684B1 (en) * 2002-06-27 2009-07-22 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
WO2004005289A2 (en) * 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007086395A1 (ja) * 2006-01-24 2007-08-02 Hamamatsu Foundation For Science And Technology Promotion 光線力学的療法用キット
JPWO2007086395A1 (ja) * 2006-01-24 2009-06-18 財団法人浜松科学技術研究振興会 光線力学的療法用キット
JP2010513363A (ja) * 2006-12-22 2010-04-30 バイオフロンテラ バイオサイエンス ゲゼルシャフト ミット ベシュレンクテル ハフツング ナノエマルジョン
JP2016193951A (ja) * 2008-11-07 2016-11-17 クロクス テクノロジーズ インコーポレイテッド 創傷治癒のための酸化剤および光活性化剤の組み合わせ
JP2012508190A (ja) * 2008-11-07 2012-04-05 クロクス テクノロジーズ インコーポレイテッド ヒアルロン酸、グルコサミン、およびアラントインを含む、酸化的光活性化皮膚再生組成物
JP2016193950A (ja) * 2008-11-07 2016-11-17 クロクス テクノロジーズ インコーポレイテッド ヒアルロン酸、グルコサミン、およびアラントインを含む、酸化的光活性化皮膚再生組成物
JP2013253110A (ja) * 2008-11-07 2013-12-19 Klox Technologies Inc ヒアルロン酸、グルコサミン、およびアラントインを含む、酸化的光活性化皮膚再生組成物
JP2013253109A (ja) * 2008-11-07 2013-12-19 Klox Technologies Inc 創傷治癒のための酸化剤および光活性化剤の組み合わせ
JP2012508189A (ja) * 2008-11-07 2012-04-05 クロクス テクノロジーズ インコーポレイテッド 創傷治癒のための酸化剤および光活性化剤の組み合わせ
JP2016020386A (ja) * 2008-11-07 2016-02-04 クロクス テクノロジーズ インコーポレイテッド ヒアルロン酸、グルコサミン、およびアラントインを含む、酸化的光活性化皮膚再生組成物
JP2016006120A (ja) * 2008-11-07 2016-01-14 クロクス テクノロジーズ インコーポレイテッド 創傷治癒のための酸化剤および光活性化剤の組み合わせ
US10688172B2 (en) 2009-04-13 2020-06-23 INSERM (Institut National de la Santé et de la Recherche Médicale) HPV particles and uses thereof
JP2012533522A (ja) * 2009-07-17 2012-12-27 クロクス テクノロジーズ インコーポレイテッド 口腔内消毒および口腔疾患の処置のための酸化剤、光増感剤および創傷治癒剤の組み合わせ
JP2014518660A (ja) * 2011-04-29 2014-08-07 ホピトー ユニヴァーシテアーズ ド ジュネーヴ 角膜疾患を治療および／または予防するための装置
KR20140048878A (ko) * 2011-04-29 2014-04-24 오삐또 유니베르시테르 드 제네브 각막 질환의 치료 및/또는 예방을 위한 장치
US10182941B2 (en) 2011-04-29 2019-01-22 Farhad Hafezi Apparatus for the treatment and/or prevention of corneal diseases
KR101995083B1 (ko) * 2011-04-29 2019-07-02 파하드 하페치 각막 질환의 치료 및/또는 예방을 위한 장치
US10300150B2 (en) 2012-02-07 2019-05-28 Aura Biosciences, Inc. Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
US10596275B2 (en) 2012-02-07 2020-03-24 Aura Biosciences, Inc. Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
JP2014185151A (ja) * 2013-03-22 2014-10-02 Wuxi Zhaozhen Radiation Technology Co Ltd 速立酸素による病気を治療するウィルス不活薬物を調製する応用
JP2019013249A (ja) * 2013-09-18 2019-01-31 オーラ バイオサイエンシーズ， インコーポレイテッド 腫瘍を診断および処置するためのウイルス様粒子結合体
US10588984B2 (en) 2013-09-18 2020-03-17 Aura Biosciences, Inc. Virus-like particle conjugates for diagnosis and treatment of tumors
JP2016531591A (ja) * 2013-09-18 2016-10-13 オーラ バイオサイエンシーズ， インコーポレイテッド 腫瘍を診断および処置するためのウイルス様粒子結合体
US11110181B2 (en) 2013-09-18 2021-09-07 Aura Biosciences, Inc. Virus-like particle conjugates for diagnosis and treatment of tumors
US11806406B2 (en) 2013-09-18 2023-11-07 Aura Biosciences, Inc. Virus-like particle conjugates for diagnosis and treatment of tumors
US12029794B2 (en) 2013-09-18 2024-07-09 Biosciences, Inc. Virus-like particle conjugates for diagnosis and treatment of tumors
JP2017517534A (ja) * 2014-06-09 2017-06-29 クロクス テクノロジーズ インコーポレイテッド シリコンベースの生体光組成物およびその使用
JP7017311B2 (ja) 2014-06-09 2022-02-08 広東科洛克生物医薬集団有限公司 シリコンベースの生体光組成物およびその使用
US11266685B2 (en) 2014-06-09 2022-03-08 Klox Technologies Inc. Silicone-based biophotonic compositions and uses thereof
US12589165B2 (en) 2017-04-12 2026-03-31 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors

Also Published As

Publication number Publication date
WO2003061696A2 (en) 2003-07-31
WO2003061696A3 (en) 2003-11-20
CA2473924A1 (en) 2003-07-31
EP1467760A2 (en) 2004-10-20
US20030167033A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
JP2005527493A (ja) 光線力学療法のためのシステムおよび方法
US6984655B1 (en) Photodynamic therapy for selectively closing neovasa in eyeground tissue
US6443976B1 (en) Methods for treating conditions and illnesses associated with abnormal vasculature
Wilson Photodynamic therapy for cancer: principles
Gomer et al. Photodynamic therapy of intraocular tumors examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue
US5405369A (en) Photochemical ablation of gastro-intestinal tissue for augmentation of an organ
JP2005527493A5 (https=)
AU750633B2 (en) Improved method for targeted topical treatment of disease
JP2002534218A (ja) 非侵襲性の脈管療法
KR20060126470A (ko) 국소 지방 세포 감소용 광선역학 치료법
Kim et al. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness
AU2002314846B2 (en) Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
US20090259167A1 (en) Methods and compositions for dose-dependent photodynamic therapy of disorders
AU2002314846A1 (en) Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
US20060258629A1 (en) Photodynamic therapy for ocular neovascularization
US20100010482A1 (en) Enhanced Photodynamic Therapy Treatment and Instrument
Solban et al. Targeted optical imaging and photodynamic therapy
Spitzer et al. Photodynamic therapy in gynecology
Davidorf et al. Treatment of iris melanoma with photodynamic therapy
Kaye et al. A review of photoradiation therapy in the management of central nervous system tumours
JP2007521890A (ja) 前立腺状態の治療のための光線力学療法
DeLaney Photodynamic therapy
Akens et al. Photodynamic Therapy
Solban et al. The need for optical imaging in the understanding and optimization of photodynamic therapy

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060120

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060120

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070827

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070827

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090324

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090623

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090630

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090929